NRI
Neurological
Reflex
Imaging
A new standard for diagnostics
Redefining how neurological diseases are
diagnosed and managed.
About Us
AlgoSensus was formed to leverage our technological expertise in AI, Machine Learning, and Robotics to focus on healthcare applications including health information, data science, and medical devices. Born out of years of research, our innovations include a novel method to diagnose a range of neurological disorders using our proprietary AI based software applications and devices. Our first product launch, the Kinezio Stability Measurement System identifies stability inadequacies due to neurological disorders and offers a solution for treatment and monitoring that improves outcomes.
Mission
Harnessing AlgoSensus' unique data from our proprietary Kinezio (Stability Algorithms) sensors and advanced AI technology, we are developing cutting-edge predictive diagnostics based on medical devices which will reduce time to diagnosis and dependencies on medical investigations such as MRIs. These simple devices combined with our unique AI solutions enable precise assessments of brain functionality and stability. By integrating IoT and Big Data, we deliver solutions that drive better treatment protocols and outcomes for falls among the elderly and across a variety of neurological conditions such as Parkinson's, Alzheimer's, and others.
Our Vision
A world leader in predictive diagnostics, leveraging advanced AI, Stability Algorithms, and IoT technology to revolutionize the detection and management of chronic diseases, while improving treatment outcomes and enhancing lives globally.
A Novel, Hyper-Interactive, Big Data Diagnostics & Monitoring System
Using unique data extracted from force sensors (our proprietary Kinezio technology), we measure stability and gravitational balance, creating a personalized and individualized topographic map. As our stability is controlled and monitored by an intricate relationship between brain, peripheral and vestibular networks, we have developed advanced AI technology that enables us to extract and manipulate data with precision to assess brain performance and functionality, based on medical devices.
Our Kinezio Platform
and its Components
Hyper-personalized Stability analytics for clinical and at-home use. In contrast to competitors which provide only on-device solutions, Our Kinezio platform is a dynamic system that constantly improves via global data collection and provides a complete solution – from assessment through monitoring and providing personalized treatment with physical exercises and Reaction Time Training (Reflex) at a Moderate Price Point Reducing Barrier to Entry/Expand Market Adoption.
The Business Model
Our usage-based subscription fees create scalable, recurring revenue streams across multiple user segments, including physical therapy and medical clinics, senior living establishments, rehabilitation hospitals, and consumer users.
Competitive Advantage
Traditional balance assessments rely on subjective physical evaluations or limited instrumentation, often lacking precision and depth. AlgoSensus revolutionizes this space by combining IoT, AI-driven Big Data, and proprietary algorithms to target the neurological roots of instability. Our cutting-edge approach delivers the industry’s most precise and impactful balance assessments, including advanced reflex (reaction time) analysis.
Our Team
Yoram Ben-Porat
Chairman
Serial entrepreneur with 40+ years of experience scaling technology, retail, and medical-device companies globally, leading IPOs and M&As with Fortune 500 acquirers.
Shlomo Talitman
CEO
Over 35 years as a senior executive in private and public companies, leading M&As, NASDAQ IPOs, and ventures in retail and healthcare technologies, including serving as CEO of Shekel Scales and a senior executive at a U.S. Investment Bank’s Israel branch.
Robert F. Hussey
COO
New York-based financial, marketing, and operations executive with Fortune 100 experience and entrepreneurial expertise. Founded the U.S.’s first direct broadcast satellite radio network and led its NASDAQ IPO. Former CEO of Digital Lightwave, Inc. (NASDAQ), Chairman of NUR Macroprinters (NASDAQ/Israel), and Brand Consultant to Dubai-based Apparel UAE.
Neta Bar, Ph.D.
CDSO
Passionate Data Scientist with a PhD in Earth Science and over a decade of scientific research, algorithm development, and data-driven insights. Experienced in applying Python and data science libraries to solve complex problems. Ph.D. Earth Science - Yale University M.Sc. Geology, B.Sc. Geological and Environmental Science.
Joe Giglio
Director of Business Development
30+ years of experience in global medical equipment. Successfully launched new medical technology and developed winning strategies.
Dr. Uri Itai, Ph.D
Head of AI Engineering
Over a decade of experience as an algorithm developer and data scientist, specializing in AI load cells and the intersection of machine learning and cyber technologies.
Dr. Johnathan Reiner
Senior Neurologist
Movement disorders specialist with extensive scientific and clinical experience in Israel, the UK, and the US. Director of the Neuromodulation and Deep Brain Stimulation Service at Rabin Medical Center. Holds an MBBS/MD from University College London (UCL) and a B.Sc. in Neuroscience (Distinction) from King’s College London.